Search Within

Sarat Chandarlapaty

Formats
  1. Meeting Abstract (143)
  2. Journal Article (126)
  3. Review (9)
  4. Editorial (3)
  5. Guidelines (2)
  6. Book Section (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (284)
  2. Breast Medicine Service (284)
  3. Department of Medicine (284)
  4. GSK Faculty (284)
  5. Human Oncology and Pathogenesis Program (284)
  6. Solid Tumor Oncology Division (284)

More Groups

People
  1. Pedram Razavi (78)
  2. Jorge Reis-Filho (64)
  3. Neal Rosen (57)
  4. Shanu Modi (51)
  5. Jose Baselga (48)
  6. Britta Weigelt (42)

More People

Years
  1. 2025 (14)
  2. 2024 (30)
  3. 2023 (17)
  4. 2022 (25)
  5. 2021 (23)
  6. 2020 (33)

More Years

Publications
  1. Cancer Research (65)
  2. Journal of Clinical Oncology (53)
  3. Annals of Oncology (21)
  4. Cancer Discovery (11)
  5. Clinical Cancer Research (11)
  6. Laboratory Investigation (11)

More Publications

Publishers
  1. American Association for Cancer Research (90)
  2. American Society of Clinical Oncology (57)
  3. Nature Publishing Group (37)
  4. Oxford University Press (24)
  5. Cell Press (14)
  6. Elsevier Inc. (11)

More Publishers

Results (284)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • TBCRC 058: A randomized phase II study of enzalutamide, enzalutamide with mifepristone, and treatment of physician's choice in patients with androgen receptor-positive metastatic triple-negative or estrogen receptor-low breast cancer (NCT06099769)
    Meeting Abstract

    Traina, T. A.; Chen, Y.; Khoury, K.; Rugo, H. S.; Mayer, E. L.; Abdou, Y.; Melisko, M. E.; Pareja, F.; Weigelt, B.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ultrasensitive ctDNA monitoring during CDK4/6 inhibitor therapy for metastatic breast cancer
    Meeting Abstract

    Ah-Reum An, J.; Jasper, J.; Cabel, L.; Yildirim, S. Y.; da Silva, E. M.; Patel, R. K.; LaBella, M.; Teysir, J.; Mai, N.; Safonov, A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Circulating tumor DNA (ctDNA) dynamics as a predictor of treatment response in metastatic breast cancer (mBC)
    Meeting Abstract

    Razavi, P.; Cabel, L.; Teysir, J.; An, J. A. R.; Rivero-Hinojosa, S.; Satta, S.; Bristow, S. L.; Kalashnikova, E.; Rodriguez, A. A.; Liu, M. C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Inhibition of NR2F2 restores hormone therapy response to endocrine refractory breast cancers
    Journal Article

    Cai, Y.; Zhao, P.; Wu, F.; Zhao, H.; Shao, H.; Marra, A.; Patel, P.; O’Connell, E.; Fink, E.; Miele, M. M.; more...
    Science Translational Medicine (2025)

    Fulltext@MSK | Save
  • Sequential antibody-drug conjugate therapy in patients with metastatic breast cancer treated with sacituzumab govitecan and trastuzumab deruxtecan
    Journal Article

    Mai, N.; Lieberman, M. M. K.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Genomic and transcriptomic profiling of primary tumors from patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC) in the monarchE trial
    Meeting Abstract

    Rubenstein, C. S.; Turner, N.; Reis, J. S.; Goetz, M. P.; Desmedt, C.; Chandarlapaty, S.; Sasano, H.; Arteaga, C. L.; Loi, S.; Graff, S. L.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Prognostic utility of ctDNA detection in the monarchE trial of adjuvant abemaciclib plus endocrine therapy (ET) in HR+, HER2-, node-positive, high-risk early breast cancer (EBC)
    Meeting Abstract

    Loi, S.; Johnston, S.; Arteaga, C.; Graff, S.; Chandarlapaty, S.; Goetz, M.; Desmedt, C.; Sasano, H.; Liu, D.; Rodrik-Outmezguine, V.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Co-occurrence of PI3K pathway gene alterations in endometrial cancer molecular subtypes at the single cell level
    Meeting Abstract

    Da Cruz Paula, A.; Zhu, Y.; Brown, D.; Pareja, F.; de Oliveira, T. B.; Dopeso, H.; da Silva, E. M.; Chandarlapaty, S.; Abu-Rustum, N.; Reis, J.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save